INNATE PHARMA (EPA:IPH) INNATE PHARMA RELEASES ITS FINANCIAL CALENDAR FOR 2020
Retour
Directive transparence : information réglementée
04/12/2019 07:00
Tweeter
04/12/2019 07:00
INNATE PHARMA RELEASES ITS FINANCIAL CALENDAR FOR 2020
03/12/2019 07:00
Innate Pharma Certified as a Great Place to Work®
13/11/2019 07:00
Innate Pharma third quarter 2019 report
13/09/2019 14:30
Innate Pharma : HALF-YEAR FINANCIAL REPORT 2019
13/09/2019 07:00
Innate Pharma reports first half 2019 financial results and business update
20/06/2019 07:00
Innate Pharma to host key opinion leader call on IPH4102 “TELLOMAK”...
12/06/2019 10:00
Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and...
11/12/2012 07:15
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) updates on four...
23/11/2012 07:30
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) announces that its...
14/11/2012 07:15
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) announces revenue...
Voir tous les communiqués de INNATE PHARMA